The University of Chicago Header Logo

Connection

Hans Schreiber to Oncolytic Virotherapy

Back to Details
This is a "connection" page, showing publications Hans Schreiber has written about Oncolytic Virotherapy.
Hans Schreiber
Connection Strength
0.178
Oncolytic Virotherapy
  1. LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor ß Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models. Hum Gene Ther. 2020 08; 31(15-16):863-880.
    View in: PubMed
    Score: 0.178
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.